Cohere Health, a leading U.S.-based AI-powered clinical intelligence company, has inaugurated its first Global Capability Centre (GCC) in Hyderabad to accelerate development and scaling of its AI-driven utilization management, prior authorization, and clinical decision support solutions. The new centre will serve as a major innovation and engineering hub, leveraging India’s deep AI talent pool to enhance Cohere’s platform for payers, providers, and health systems globally while supporting faster deployment of evidence-based care pathways.
Glimpse:
The Hyderabad GCC will focus on AI model development, data engineering, product innovation, and 24/7 support for Cohere’s clinical intelligence platform, which uses AI to automate prior authorizations, reduce administrative burden, and align care decisions with the latest clinical guidelines. The expansion is expected to create hundreds of high-skill jobs in AI, machine learning, and healthcare informatics, while strengthening Cohere’s ability to serve U.S. health plans and providers with more accurate, faster, and compliant utilization management solutions.
Cohere Health, a fast-growing U.S.-based healthtech company specializing in AI-powered clinical intelligence and utilization management, has officially opened its first Global Capability Centre (GCC) in Hyderabad, Telangana. The inauguration took place on February 27, 2026, and marks a significant milestone in Cohere’s global growth strategy, tapping into India’s world-class AI and engineering talent to accelerate innovation and scale its platform for healthcare payers and providers.
The Hyderabad GCC will serve as Cohere’s primary hub for advanced AI and machine learning development, data engineering, product management, and round-the-clock operational support. Teams at the centre will work on enhancing Cohere’s core clinical decision intelligence engine, which automates prior authorization workflows, applies real-time evidence-based guidelines, reduces inappropriate care variations, and improves approval turnaround times for payers while supporting providers with faster, more transparent decisions. The platform already processes millions of clinical requests annually for major U.S. health plans, and the new centre will help expand its capabilities to handle greater volume, complexity, and specialty-specific pathways.
Cohere’s leadership highlighted Hyderabad’s emergence as a global healthtech and AI hub, citing the city’s strong talent ecosystem, proximity to leading academic institutions like IIT Hyderabad and IIIT Hyderabad, and robust digital infrastructure. The GCC is expected to grow rapidly, creating hundreds of high-skill jobs in AI/ML engineering, clinical informatics, data science, product development, and healthcare domain expertise over the next 2–3 years. The centre will also collaborate closely with Cohere’s U.S. teams to ensure seamless integration of India-developed innovations into the core platform.
The launch reflects a broader trend of U.S. healthtech companies establishing GCCs in India to drive cost-effective innovation while maintaining world-class quality and compliance (HIPAA, HITRUST, SOC 2). Cohere emphasized that all data handling remains fully compliant with U.S. privacy and security regulations, with no patient-identifiable information processed or stored in India. The Hyderabad team will focus on model training, algorithm optimization, workflow automation, and scalability enhancements using anonymized and synthetic datasets.
This move strengthens Cohere’s ability to deliver faster, more accurate prior authorization decisions and clinical guidance at scale ultimately reducing administrative burden on providers, improving patient access to timely care, and lowering unnecessary costs for payers. The company plans to continue expanding its India presence with additional hiring and potential future centres to support its ambitious growth trajectory in the U.S. healthcare market.
“Hyderabad’s talent and innovation ecosystem make it the perfect place to scale Cohere’s AI clinical intelligence platform. This GCC will help us deliver smarter, faster, and more equitable care decisions for millions of patients.”
By
HB Team
Related News
